These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 32638437)

  • 1. Reference interval and the role of soluble suppression of tumorigenicity 2 (sST2) in subclinical cardiac dysfunction at health checkups.
    Nah EH; Cho S; Kim S; Cho HI
    J Clin Lab Anal; 2020 Nov; 34(11):e23461. PubMed ID: 32638437
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Suppression of Tumorigenicity 2 in Heart Failure With Preserved Ejection Fraction.
    AbouEzzeddine OF; McKie PM; Dunlay SM; Stevens SR; Felker GM; Borlaug BA; Chen HH; Tracy RP; Braunwald E; Redfield MM
    J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28214792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. sST2 as a New Biomarker of Chronic Kidney Disease-Induced Cardiac Remodeling: Impact on Risk Prediction.
    Plawecki M; Morena M; Kuster N; Chenine L; Leray-Moragues H; Jover B; Fesler P; Lotierzo M; Dupuy AM; Klouche K; Cristol JP
    Mediators Inflamm; 2018; 2018():3952526. PubMed ID: 30402040
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble ST2 has a prognostic role in patients with suspected sepsis.
    Hur M; Kim H; Kim HJ; Yang HS; Magrini L; Marino R; Cardelli P; Di Somma S;
    Ann Lab Med; 2015 Nov; 35(6):570-7. PubMed ID: 26354344
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Value of Soluble ST2 After Myocardial Infarction: A Community Perspective.
    Jenkins WS; Roger VL; Jaffe AS; Weston SA; AbouEzzeddine OF; Jiang R; Manemann SM; Enriquez-Sarano M
    Am J Med; 2017 Sep; 130(9):1112.e9-1112.e15. PubMed ID: 28344136
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soluble ST2 and CXCL-10 may serve as biomarkers of subclinical diastolic dysfunction in SLE and correlate with disease activity and damage.
    Chorin E; Hochstadt A; Arad U; Ghantous E; Gertel S; Levartovsky D; Litinsky I; Elaluof O; Polachek A; Kaufman I; Aloush V; Borok S; Wigler I; Wollman J; Caspi D; Laufer-Perl M; Letourneau-Shesaf S; Berliner S; Elkayam O; Topilsky Y; Paran D
    Lupus; 2020 Oct; 29(11):1430-1437. PubMed ID: 32772796
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soluble ST2 Levels and Left Ventricular Structure and Function in Patients With Metabolic Syndrome.
    Celic V; Majstorovic A; Pencic-Popovic B; Sljivic A; Lopez-Andres N; Roy I; Escribano E; Beunza M; Melero A; Floridi F; Magrini L; Marino R; Salerno G; Cardelli P; Di Somma S
    Ann Lab Med; 2016 Nov; 36(6):542-9. PubMed ID: 27578507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Establishment of reference intervals for soluble ST2 from a United States population.
    Lu J; Snider JV; Grenache DG
    Clin Chim Acta; 2010 Nov; 411(21-22):1825-6. PubMed ID: 20654603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relations of circulating GDF-15, soluble ST2, and troponin-I concentrations with vascular function in the community: The Framingham Heart Study.
    Andersson C; Enserro D; Sullivan L; Wang TJ; Januzzi JL; Benjamin EJ; Vita JA; Hamburg NM; Larson MG; Mitchell GF; Vasan RS
    Atherosclerosis; 2016 May; 248():245-51. PubMed ID: 26972631
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distribution and clinical correlates of the interleukin receptor family member soluble ST2 in the Framingham Heart Study.
    Coglianese EE; Larson MG; Vasan RS; Ho JE; Ghorbani A; McCabe EL; Cheng S; Fradley MG; Kretschman D; Gao W; O'Connor G; Wang TJ; Januzzi JL
    Clin Chem; 2012 Dec; 58(12):1673-81. PubMed ID: 23065477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Structural heart disease and ST2: cross-sectional and longitudinal associations with echocardiography.
    deFilippi C; Daniels LB; Bayes-Genis A
    Am J Cardiol; 2015 Apr; 115(7 Suppl):59B-63B. PubMed ID: 25702279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predicting long-term cardiovascular outcomes of patients with acute myocardial infarction using soluble ST2.
    Somuncu MU; Kalayci B; Avci A; Akgun T; Karakurt H; Demir AR; Avci Y; Can M
    Horm Mol Biol Clin Investig; 2020 Feb; 41(2):. PubMed ID: 32112700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ST2 elevation in heart failure, predictive of a high early mortality.
    Dalal JJ; Digrajkar A; Das B; Bansal M; Toomu A; Maisel AS
    Indian Heart J; 2018; 70(6):822-827. PubMed ID: 30580851
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Soluble ST2 proteins in male cachectic patients with chronic heart failure.
    Sobieszek G; Powrózek T; Jaroszyński A; Skwarek-Dziekanowska A; Rahnama-Hezavah M; Małecka-Massalska T
    Nutr Metab Cardiovasc Dis; 2021 Mar; 31(3):886-893. PubMed ID: 33549461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Increased Plasma Concentrations of Soluble ST2 Independently Predict Mortality but not Cardiovascular Events in Stable Coronary Heart Disease Patients: 13-Year Follow-up of the KAROLA Study.
    Pfetsch V; Sanin V; Jaensch A; Dallmeier D; Mons U; Brenner H; Koenig W; Rothenbacher D
    Cardiovasc Drugs Ther; 2017 Apr; 31(2):167-177. PubMed ID: 28283847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between Soluble ST2 and Left Ventricular Geometry in Maintenance Hemodialysis Patients.
    Zhang Z; Xie Y; Shen B; Nie Y; Cao X; Xiang F; Zou J
    Blood Purif; 2021; 50(1):84-92. PubMed ID: 33291107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of soluble ST2 in adults with congenital heart disease.
    Geenen LW; Baggen VJM; van den Bosch AE; Eindhoven JA; Cuypers JAAE; Witsenburg M; Boersma E; Roos-Hesselink JW
    Heart; 2019 Jul; 105(13):999-1006. PubMed ID: 30700520
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Interleukin-33/ST2 Pathway Is Expressed in the Failing Human Heart and Associated with Pro-fibrotic Remodeling of the Myocardium.
    Tseng CCS; Huibers MMH; van Kuik J; de Weger RA; Vink A; de Jonge N
    J Cardiovasc Transl Res; 2018 Feb; 11(1):15-21. PubMed ID: 29285671
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soluble ST2 is associated with increased carotid intima-media thickness in patients with type 2 diabetes mellitus: A case-control study.
    Hu X; Zhang H; Song Y; Yang Q; Zhuang L; Jin G; Zhang S; Sun W; Shi Z
    Medicine (Baltimore); 2020 Jan; 99(5):e18940. PubMed ID: 32000412
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic Role of High-sensitivity Cardiac Troponin I and Soluble Suppression of Tumorigenicity-2 in Surgical Intensive Care Unit Patients Undergoing Non-cardiac Surgery.
    Yang HS; Hur M; Yi A; Kim H; Kim J
    Ann Lab Med; 2018 May; 38(3):204-211. PubMed ID: 29401554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.